Well-done: Prof Dr Zilfalil is among the authors of a recently published article in the prestigious Nature Medicine research journal.
Consultant child specialist and medical geneticist from Universiti Sains Malaysia (USM), Prof Dr Zilfalil Alwi (pic), who made history when he was appointed to the Technical Advisory Group on Genomics (TAG-G) as its sole Malaysian member last year, has again done the country proud by being listed as among the authors of an article published in Nature Medicine, a prestigious research journal for scientists and doctors which focuses on clinical and translational advancements.
Prepared by members of TAG-G, and published on Sept 3, “The World Health Organization (WHO) Genomics Programme for Equitable Implementation of Human Genomics for Global Health” working paper emphasised the importance of human genomics to global health, a press release from USM read.
There have been significant advancements in human genomics, particularly since the publication of the first draft of the human genome sequence in 2001, which have revolutionised the diagnosis, treatment, and prevention of diseases through the sequencing of millions of genomes and the discovery of numerous gene-disease associations.
Access to these groundbreaking technologies, however, remains uneven, especially in low- and middle-income countries.
This disparity is largely due to resource limitations and low adoption capabilities within the health systems.
The comprehensive WHO Genomics Programme, guided by the TAG-G, was launched to advance equitable access to genomics technologies across the globe by promoting investments, fostering collaborations, and overcoming obstacles to the widespread implementation of genomics.
Key actions of the programme include targeted communication efforts to highlight the benefits of genomics, the development of investment scenarios tailored to regional needs, and the establishment of principles for the ethical use and sharing of genomic data.
The success of the programme, which also aims to ensure a coordinated, global approach to human genomics, hinges on the collective efforts of governments, communities, and the private sector to ensure that the benefits of genomics are accessible to all, particularly the most underserved populations.
